4/20/22 16:05 | 4/19/22 | INZY | Inozyme Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Subramanian Sanjay | MA | O | SVP,CFO | P | 100 | 3.69 | 0 | 27 | New | 27 | D | | | | | | | | | | | | | | |
10/27/21 17:09 | 10/26/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | S | -111 | 11.07 | 0 | -10 | -22 | 36 | D | | | | | | | | | | | | | | |
10/15/21 16:01 | 10/15/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | M.d | 17 | 2.19 | 0 | 8 | 21 | 46 | D | | | | | | | | | | | | | | |
10/15/21 16:01 | 10/15/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | S.d | -80 | 9.96 | 0 | -8 | -15 | 46 | D | | | | | | | | | | | | | | |
8/18/21 16:01 | 8/16/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | M.d | 10 | 0.3400 | 0 | 30 | 192 | 46 | D | | | | | | | | | | | | | | |
8/18/21 16:01 | 8/16/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | S.d | -217 | 7.22 | 0 | -30 | -40 | 46 | D | | | | | | | | | | | | | | |
7/16/21 16:01 | 7/15/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | M.d | 11 | 0.3400 | 0 | 31 | 214 | 46 | D | | | | | | | | | | | | | | |
7/16/21 16:01 | 7/15/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | S.d | -208 | 6.70 | 0 | -31 | -41 | 46 | D | | | | | | | | | | | | | | |
6/17/21 17:25 | 6/15/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | M.d | 11 | 0.3400 | 0 | 31 | 212 | 46 | D | | | | | | | | | | | | | | |
6/17/21 17:25 | 6/15/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | S.d | -217 | 7.00 | 0 | -31 | -40 | 46 | D | | | | | | | | | | | | | | |
5/14/21 16:58 | 5/14/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | M.d | 11 | 0.3400 | 0 | 31 | 212 | 46 | D | | | | | | | | | | | | | | |
5/14/21 16:58 | 5/14/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | S.d | -254 | 8.18 | 0 | -31 | -40 | 46 | D | | | | | | | | | | | | | | |
5/3/21 21:06 | 4/29/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | M.d | 17 | 2.19 | 0 | 8 | 21 | 46 | D | | | | | | | | | | | | | | |
5/3/21 21:06 | 4/29/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | S.d | -88 | 10.98 | 0 | -8 | -15 | 46 | D | | | | | | | | | | | | | | |
2/1/21 17:31 | 1/29/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Subramanian Sanjay | PA | O | CFO | M.d | 18 | 0.5100 | 0 | 36 | 356 | 46 | D | | | | | | | | | | | | | | |
11/26/19 19:17 | 11/22/19 | OCGN | Ocugen, Inc. | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Subramanian Sanjay | PA | O | CFO | P | 1 | 0.2800 | 0 | 5 | 100 | 10 | D | | | | | | | | | | | | | | |
10/4/19 13:36 | 10/2/19 | OCGN | Ocugen, Inc. | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Subramanian Sanjay | PA | O | CFO | P.d | 9 | 1.88 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |